Can HUVS Cause Permanent Lung Damage or Airway Obstruction?

Yes, Hypocomplementemic Urticarial Vasculitis Syndrome (HUVS) can cause lung damage, including an obstructive airway disease that mimics chronic obstructive pulmonary disease (COPD). While HUVS-related lung disease can be severe and sometimes permanent, the risk and severity vary widely from person to person. Because HUVS is a rare disease, much of our medical knowledge comes from case reports and small studies ^[1]. For example, in one small Swedish study of 16 patients, 63% had some form of lung disease after long-term follow-up, though not all of these instances were severe ^[1].

How HUVS Affects the Lungs

When the immune system inflammation of HUVS targets the respiratory tract, it can cause structural changes in the lungs. A well-documented manifestation is emphysema (the destruction of the tiny air sacs in the lungs), which leads to severe airway obstruction ^[2]. Because the damaged lungs lose their elasticity, air becomes trapped inside when you exhale—a condition known as hyperinflation ^[2][3].

Patients may experience symptoms such as:

• Breathlessness, particularly during exertion or exercise ^[2][4]
• Chronic cough ^[5]
• Wheezing or a feeling of tightness in the chest
• Difficulty moving air out of the lungs (obstructive airway disease) ^[6]

Other uncommon complications can include pulmonary hemorrhage (bleeding in the lungs) ^[7]. Patients may also have a higher risk of lung infections, such as pneumonia. This infection risk can be related to the structural damage in the lungs or the immunosuppressive medications used to treat HUVS ^[8][9]. Keep in mind that not every cough or episode of breathlessness means vasculitis is attacking your lungs—symptoms can also be caused by standard respiratory infections, asthma, or other common issues.

Is the Lung Damage Permanent?

Because severe HUVS can cause physical destruction of lung tissue (like emphysema), some impairment can be irreversible ^[6]. Case reports have noted fixed airflow limitation even in young patients who have never smoked ^[6].

While systemic treatments for HUVS (such as oral steroids or immunosuppressants) help control whole-body inflammation, they may not reverse established structural lung damage ^[3]. However, symptoms can still be managed. Early recognition is important to tailor treatments and limit progression ^[4]. Additionally, targeted treatments like inhaled bronchodilators or inhaled corticosteroids (inhalers prescribed by a lung specialist) may provide marked relief of breathing symptoms for some patients, even when structural damage persists ^[3].

Taking Action: Protecting Your Lungs

Because early lung involvement can be subtle, proactive monitoring and communication with your care team (which may include a pulmonologist, or lung specialist) are essential.

• Pulmonary Function Testing (PFTs): These tests involve blowing into a machine to measure how much air your lungs hold and how quickly you can blow it out. While strict guidelines for exactly how often to test do not exist for this rare disease ^[10], baseline testing and individualized periodic follow-ups can help your doctor catch any decline early ^[2][4].
• Chest Imaging: Your doctor may recommend a high-resolution chest CT scan if you develop new symptoms or if your PFTs show abnormalities ^[2]. CT scans are not automatically required for every patient without symptoms, as they involve radiation.
• Avoid Smoke and Irritants: Smoking is known to significantly worsen lung disease in HUVS, so completely avoiding tobacco and vaping is strongly recommended ^[11]. However, nonsmokers can still develop severe lung disease from the vasculitis alone, so everyone with HUVS requires symptom monitoring ^[6].
• Urgent vs. Emergency Care:
  • Call your care team promptly if you have a new persistent cough, a fever, or suspect you have a lung infection.
  • Seek emergency medical care if you experience rapidly worsening shortness of breath, severe breathing difficulty at rest, chest pain, blue lips, or if you cough up blood ^[7][4].